GO:0004190 aspartic-type endopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004190 describes aspartic-type endopeptidase activity, a molecular function where a water molecule activated by two aspartic acid residues cleaves internal peptide bonds in proteins.
• This activity is essential for diverse biological processes, including protein catabolism, viral maturation, and milk clotting.
• Key enzymes include pepsin, cathepsin D, renin, and retroviral proteases such as HIV-1 protease.
• Dysregulation of aspartic proteases is linked to neurodegenerative diseases, cancer, and kidney stone formation.
• Studying these enzymes requires methods like site-directed mutagenesis, enzyme assays, and structural biology.
• CRISPR-based models enable precise knockout, point mutation, and knock-in of aspartic protease genes for functional studies.
Description
Aspartic-type endopeptidase activity (GO:0004190) is a fundamental molecular function that catalyzes the hydrolysis of internal alpha-peptide bonds in polypeptides. This activity relies on a catalytic mechanism where a water molecule, bound by the side chains of two aspartic residues in the active site, acts as a nucleophile. Aspartic proteases are found across all kingdoms of life and play critical roles in processes ranging from digestion to viral maturation. In humans, dysregulation of these enzymes is associated with severe pathologies, including neurodegenerative disorders and cancer. Understanding the structure, mechanism, and regulation of aspartic proteases is therefore of broad biomedical importance. This article provides a comprehensive overview of GO:0004190, covering its definition, biological significance, key genes, disease links, and research methodologies, with a focus on how CRISPR-based models can accelerate discovery.
aspartic-type endopeptidase activity At A Glance
| GO ID | GO:0004190 |
|---|---|
| GO term | aspartic-type endopeptidase activity |
| Ontology | molecular_function |
| Synonym | aspartate protease activity; aspartic endopeptidase activity; aspartic protease activity; aspartyl protease activity; carboxyl protease activity |
| Major function | Hydrolysis of internal alpha-peptide bonds in polypeptides using a water molecule activated by aspartic residues |
| EC number | 3.4.23.- |
| Catalytic residues | Two aspartic acid residues (Asp) in the active site |
| Optimal pH | Typically acidic (pH 2-6) |
| Inhibitors | Pepstatin A, HIV protease inhibitors |
What Is GO:0004190?
Aspartic-type endopeptidase activity (GO:0004190) is defined as the catalysis of internal peptide bond hydrolysis in a polypeptide chain. The mechanism involves a water molecule that is activated by the side chains of aspartic acid residues at the active center, which acts as a nucleophile to cleave the peptide bond. This activity is synonymous with aspartate protease, aspartic endopeptidase, aspartic protease, aspartyl protease, and carboxyl protease activities.
Why Is aspartic-type endopeptidase activity Important in Cell Biology?
Aspartic-type endopeptidases are critical for numerous physiological and pathological processes. They are essential for protein turnover, hormone processing, and viral replication. In humans, cathepsin D is implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, while renin regulates blood pressure. In cancer, aspartic proteases can promote invasion and metastasis. Moreover, retroviral aspartic proteases, like HIV-1 protease, are prime drug targets. Understanding GO:0004190 is thus vital for drug development and disease modeling.
• Essential for protein catabolism and turnover in lysosomes and digestive tracts.
• Critical for viral maturation, as in HIV-1 protease, a major drug target.
• Involved in milk clotting, with applications in cheese production.
• Dysregulation linked to neurodegenerative diseases like Alzheimer's.
• Associated with cancer progression and metastasis.
• Plays a role in kidney stone formation via aspartame metabolism.
• Secreted by fungi such as Trichosporon asahii as a virulence factor.
• Modulated in intestinal mucosal proteome during infection.
• Responds to nitrogen deficiency in plants, affecting protein degradation.
• Target for inhibitors like pepstatin A and antiretroviral drugs.
What Happens During aspartic-type endopeptidase activity?
Substrate Binding and Active Site Activation
In simple terms: The enzyme grabs the protein target and uses two aspartic acid residues to activate a water molecule.
The active site of aspartic proteases contains two catalytic aspartic acid residues that bind and activate a water molecule. This water molecule acts as a nucleophile, attacking the carbonyl carbon of the peptide bond to be cleaved. Substrate binding induces conformational changes that position the scissile bond near the catalytic dyad.
Catalytic Cleavage of the Peptide Bond
In simple terms: The activated water breaks the peptide bond, splitting the protein into two parts.
The nucleophilic water attacks the peptide bond, forming a tetrahedral transition state stabilized by the aspartic residues. Subsequent proton transfer leads to bond cleavage, releasing two peptide fragments. This mechanism is conserved across aspartic proteases from viruses to humans.
Product Release and Enzyme Recycling
In simple terms: The enzyme releases the cleaved protein pieces and is ready to work again.
After cleavage, the products are released from the active site, and the enzyme returns to its original conformation for another round of catalysis. The catalytic aspartates are regenerated for the next reaction cycle.
Regulation by pH and Inhibitors
In simple terms: The enzyme's activity depends on the acidity of its environment and can be blocked by specific molecules.
Aspartic proteases typically function optimally at acidic pH, where the aspartic residues are protonated appropriately. Inhibitors such as pepstatin A bind tightly to the active site, blocking substrate access. In vivo, activity is also regulated by zymogen activation and compartmentalization.
Key Genes Involved in GO:0004190 aspartic-type endopeptidase activity
The following genes encode proteins with aspartic-type endopeptidase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PGA5 (Pepsinogen A5) | Digestive protease in stomach | Studied for gastric function and milk clotting |
| CTSD (Cathepsin D) | Lysosomal protease | Implicated in neurodegeneration and cancer |
| REN (Renin) | Blood pressure regulation | Target for hypertension drugs |
| BACE1 | Beta-secretase in amyloid precursor protein processing | Alzheimer's disease research |
| BACE2 | Beta-secretase homolog | Role in pigmentation and Alzheimer's |
| HIV-1 protease (pol) | Viral polyprotein processing | Antiretroviral drug target |
| PEP4 (S. cerevisiae) | Vacuolar protease | Model for vacuolar protein sorting |
| ASP1 (C. albicans) | Secreted aspartic protease | Fungal virulence factor |
| SAP1-10 (C. albicans) | Secreted aspartic proteases | Pathogenesis studies |
| Trichosporon asahii aspartic peptidase | Secreted 30-kDa peptidase | Fungal infection research |
| Moringa oleifera aspartic endopeptidase | Milk-clotting enzyme | Plant protease characterization |
| Camellia sinensis aspartic proteases | Nitrogen deficiency response | Plant stress studies |
| Oncorhynchus mykiss intestinal proteases | Mucosal proteome modulation | Fish immunity research |
| Gastric cancer-associated proteases | Cytokine expression modulation | Cancer biomarker studies |
| Kidney stone-related proteases | Aspartame metabolism | Network toxicology |
How Is aspartic-type endopeptidase activity Regulated?
Aspartic-type endopeptidase activity is regulated at multiple levels. Zymogen activation, such as the conversion of pepsinogen to pepsin in acidic environments, controls activity spatially and temporally. pH is a critical regulator, as the catalytic aspartates require protonation states optimal at acidic pH. Endogenous inhibitors, like pepstatin A in microorganisms, and therapeutic inhibitors, such as HIV protease inhibitors, block activity. In neurodegenerative diseases, cathepsin D activity is modulated by lysosomal dysfunction and oxidative stress. Additionally, transcriptional regulation in response to nitrogen deficiency has been observed in plants.
aspartic-type endopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTSD | Neurodegenerative disorders (Alzheimer's, Parkinson's) | Knockout mice, neuronal cell lines |
| BACE1 | Alzheimer's disease | Knock-in mice, iPSC-derived neurons |
| HIV-1 protease | AIDS | In vitro enzymatic assays, viral replication models |
| CTSD | Cancer (gastric, breast) | Xenograft models, CRISPR knockout cancer cells |
| Trichosporon asahii aspartic peptidase | Fungal infections | Fungal virulence models, knockout strains |
Aspartic Proteases in Neurodegenerative Disorders
Cathepsin D (CTSD), an aspartic protease, is implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Dysfunctional CTSD leads to impaired lysosomal degradation of proteins, contributing to neuronal death. BACE1, another aspartic protease, is a key enzyme in the production of amyloid-beta peptides, a hallmark of Alzheimer's disease.
Aspartic Proteases in Cancer
Cathepsin D is overexpressed in various cancers, including gastric cancer, where it correlates with cytokine expression profiles and poor prognosis. It promotes cancer cell proliferation, invasion, and metastasis by degrading extracellular matrix components. Aspartic proteases also play roles in tumor angiogenesis and immune evasion.
Viral Infections and Aspartic Proteases
Retroviral proteases, such as HIV-1 protease, are aspartic-type endopeptidases essential for viral maturation. They cleave viral polyproteins into functional units, enabling the formation of infectious virions. Inhibition of these proteases is a cornerstone of antiretroviral therapy.
Fungal Pathogenesis and Aspartic Proteases
Secreted aspartic proteases from fungi like Trichosporon asahii and Candida albicans degrade host tissues and evade immune responses, contributing to virulence. These enzymes are potential targets for antifungal drugs.
From aspartic-type endopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of CTSD in neurodegeneration? | CTSD knockout mice or CRISPR knockout neuronal cell lines |
| How does BACE1 cleavage affect amyloid-beta production? | BACE1 point mutant knock-in mice |
| Can HIV protease inhibitors be improved? | In vitro enzymatic assays with mutant proteases |
| What is the function of fungal secreted aspartic proteases? | CRISPR knockout in Candida albicans |
| How does aspartame affect kidney stone formation? | Network toxicology and molecular docking |
| What is the role of plant aspartic proteases in nitrogen stress? | Overexpression in Camellia sinensis |
How to Study the aspartic-type endopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Catalytic cleavage of peptide substrates | Screening inhibitors, characterizing kinetics |
| X-ray crystallography | Three-dimensional structure | Active site analysis, drug design |
| Site-directed mutagenesis | Effect of specific residues on activity | Identifying catalytic residues |
| Proteomics | Global protein expression and modifications | Discovering protease substrates |
| Transcriptomics | Gene expression changes | Identifying regulated proteases |
| Molecular docking | Binding affinity of inhibitors | Virtual screening |
| FRET-based assays | Real-time protease activity | High-throughput screening |
| Western blotting | Protein expression and cleavage | Validating knockout/overexpression |
Enzymatic Activity Assays
Aspartic protease activity is commonly measured using fluorogenic or chromogenic peptide substrates. For example, the milk-clotting activity of Moringa oleifera aspartic endopeptidase was assessed using skim milk. HIV protease activity is quantified using FRET-based substrates.
Structural Biology
X-ray crystallography and cryo-EM have elucidated the structures of aspartic proteases, revealing the conserved catalytic dyad and substrate binding pockets. These methods guide inhibitor design.
Site-Directed Mutagenesis
Mutating the catalytic aspartic acid residues to asparagine abolishes activity, confirming their essential role. Such studies have been performed on retroviral proteases and plant aspartic proteases.
Proteomics and Transcriptomics
Proteomic profiling of intestinal mucosa in rainbow trout revealed modulation of aspartic proteases after Yersinia ruckeri infection. Transcriptomic analysis in tea plants identified aspartic protease genes responding to nitrogen deficiency.
How CRISPR Can Be Used to Study GO:0004190 aspartic-type endopeptidase activity
Knockout
CRISPR knockout of aspartic protease genes, such as CTSD or BACE1, allows researchers to study loss-of-function phenotypes in cell lines and animal models. For example, CTSD knockout cells exhibit impaired lysosomal degradation, mimicking neurodegenerative pathology.
Point Mutation
Introducing point mutations in catalytic aspartic acid residues (e.g., D to N) via CRISPR base editing or HDR can abolish enzymatic activity while preserving protein structure, enabling the study of non-catalytic functions.
Knock-in
Knock-in of disease-associated mutations, such as those in BACE1 linked to Alzheimer's, or tagging endogenous proteases with fluorescent proteins, facilitates real-time imaging and functional studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of aspartic proteases like CTSD can model gain-of-function states observed in cancer, aiding in the identification of downstream targets.
How EDITGENE Supports aspartic-type endopeptidase activity Research
Researchers studying aspartic-type endopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic modifications, from knockout to knock-in, in various cell models.
Contact EDITGENE today to design your custom CRISPR model for aspartic-type endopeptidase activity research.
Frequently Asked Questions About aspartic-type endopeptidase activity
What is aspartic-type endopeptidase activity?
It is a molecular function (GO:0004190) where an enzyme cleaves internal peptide bonds in proteins using a water molecule activated by two aspartic acid residues.
What genes are involved in aspartic-type endopeptidase activity?
Key genes include CTSD, BACE1, REN, PGA5, and viral proteases like HIV-1 protease.
What diseases are associated with aspartic proteases?
They are linked to Alzheimer's disease, cancer, HIV/AIDS, and fungal infections.
How is aspartic protease activity regulated?
Activity is regulated by pH, zymogen activation, inhibitors, and transcriptional changes.
What is the catalytic mechanism of aspartic proteases?
Two aspartic acid residues activate a water molecule that attacks the peptide bond, leading to cleavage.
What are common inhibitors of aspartic proteases?
Pepstatin A and HIV protease inhibitors like ritonavir are common inhibitors.
How can I study aspartic protease function using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of aspartic protease genes in cells and animals.
What methods measure aspartic protease activity?
Enzyme activity assays, FRET-based assays, and milk-clotting assays are commonly used.
Are aspartic proteases involved in cancer?
Yes, cathepsin D is overexpressed in several cancers and promotes invasion and metastasis.
What is the role of aspartic proteases in plants?
They are involved in nitrogen deficiency responses and protein degradation.
Conclusion
Aspartic-type endopeptidase activity (GO:0004190) is a fundamental enzymatic function with broad biological and medical relevance. From viral maturation to neurodegeneration, these proteases are central to many physiological and pathological processes. Advances in CRISPR-based models and high-throughput methods are accelerating our understanding of their mechanisms and paving the way for novel therapeutics. EDITGENE's comprehensive services support researchers in dissecting the roles of aspartic proteases in health and disease.
References
- 1. Wang X et al.. 2021. Structural Analysis of a Novel Aspartic-Type Endopeptidase from Moringa oleifera Seeds and Its Milk-Clotting Properties.. J Agric Food Chem 69(26):7377-7387 PMID: 34180221
- 2. Xu K et al.. 2025. Analysis of toxicity and mechanisms of aspartame in kidney stones with network toxicology and molecular docking strategy.. Sci Rep 15(1):45563 PMID: 41310176
- 3. Vidoni C et al.. 2016. The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders.. Med Res Rev 36(5):845-70 PMID: 27114232
- 4. Valle RS et al.. 2017. Trichosporon asahii secretes a 30-kDa aspartic peptidase.. Microbiol Res 205:66-72 PMID: 28942846
- 5. von der Helm K. 1996. Retroviral proteases: structure, function and inhibition from a non-anticipated viral enzyme to the target of a most promising HIV therapy.. Biol Chem 377(12):765-74 PMID: 8997487
- 6. Samarina L et al.. 2024. In Vitro vs. In Vivo Transcriptomic Approach Revealed Core Pathways of Nitrogen Deficiency Response in Tea Plant (Camellia sinensis (L.) Kuntze).. Int J Mol Sci 25(21) PMID: 39519276
- 7. Quan X et al.. 2017. Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray.. Oncol Lett 14(6):7360-7366 PMID: 29344174
- 8. Kumar G et al.. 2019. Modulation of posterior intestinal mucosal proteome in rainbow trout (Oncorhynchus mykiss) after Yersinia ruckeri infection.. Vet Res 50(1):54 PMID: 31315687
